Aonong Group(SH:603363) Zheng Quan Zhi Xing·2025-03-27 08:18Core Viewpoint - Fujian Aonong Biotechnology Group Co., Ltd. is at risk of being delisted due to continuous losses from 2021 to 2023 and an audit report with an emphasis on the company's ability to continue as a going concern [1][3][4] Group 1: Reasons for Potential Delisting - The company has been under delisting risk warning since May 6, 2024, due to consecutive losses over the past three years and an audit report indicating concerns about its ongoing viability [1][3] - If the audited net assets attributable to shareholders are positive and the audit report for 2024 is unqualified, the company may apply to revoke the delisting risk warning [3][6] Group 2: Risk Warning Announcements - This announcement marks the fifth risk warning regarding potential delisting, following previous announcements made on February 14, February 28, March 14, and March 30, 2025 [2][5] - The company is required to disclose risk warning announcements every 10 trading days until the annual report is released, as per the Shanghai Stock Exchange regulations [2][5] Group 3: Other Matters - As of the date of the announcement, the audit work for the 2024 annual report is ongoing, and final financial data will be based on the officially disclosed audited report [5][6] - The company commits to fulfilling its information disclosure obligations in accordance with the relevant regulations [6]